Skip to content

Transcranial Direct Current Stimulation on the Risk of Falls and Lower Limb Function for Acute Stroke

Effects of Different Montages of Transcranial Direct Current Stimulation on the Risk of Falls and Lower Limb Function for Acute Stroke Patients: a Randomized Controlled Trial

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02422173
Enrollment
60
Registered
2015-04-21
Start date
2015-01-31
Completion date
2015-04-30
Last updated
2015-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

Transcranial direct current stimulation (tDCS) has shown promising results in the modulation of cortical excitability and the promotion of neuronal plasticity after stroke. The purpose of this study was to compare the effectiveness of three different montages of tDCS (anodal, cathodal and bilateral) in reducing the risk of falls and recovery of lower limb function in acute stroke patients.

Detailed description

This is a randomized sham-controlled trial reported following the 2010 CONSORT guidelines. The subjects were randomly allocated into 1 of 4 groups in a double-blinded parallel study design. Each patient received 10 sessions (5 consecutive days for 2 weeks) of real or sham stimulation at 2 mA intensity and current density equivalent to 0.05 A/m2.

Interventions

The active electrode is placed on the affected hemisphere

The active electrode is placed on the unaffected hemisphere

The cathode and anode is positioned as active electrodes on the unaffected and affected hemisphere,respectively.

DEVICESham transcranial direct current stimulation

Placebo stimulation, with emission current by only 30 seconds

Sponsors

Federal University of Paraíba
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of acute stroke * Able to walk 10m independently * High risk of falling

Exclusion criteria

* Severe functional limitations * Cognitive impairment

Design outcomes

Primary

MeasureTime frame
Four Square Step TestChange from Baseline in Risk of Falls at 3 months

Secondary

MeasureTime frame
Overall Stability IndexBaseline, Week 2, Week 4 and Week 12
Falls Efficacy Scale - InternationalBaseline, Week 2, Week 4 and Week 12
Occurrence of Falling IndexBaseline, Week 2, Week 4 and Week 12
Six-minute walk testBaseline, Week 2, Week 4 and Week 12
Sit to Stand TestBaseline, Week 2, Week 4 and Week 12
Berg Balance ScaleBaseline, Week 2, Week 4 and Week 12

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026